PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma

BACKGROUND AND PURPOSE: PD-1 and PD-L1 are involved in anticancer immunosurveillance, and their expression may be predictive for therapeutic effectiveness of specific antibodies. Their influence on response to neoadjuvant radiochemotherapy (RCT) and prognosis in patients with oesophageal adenocarcin...

Descripción completa

Detalles Bibliográficos
Autores principales: Göbel, Holger H., Distel, Luitpold V.R., Aigner, Thomas, Büttner-Herold, Maike J., Grabenbauer, Gerhard G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991306/
https://www.ncbi.nlm.nih.gov/pubmed/35402739
http://dx.doi.org/10.1016/j.ctro.2022.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991306/
https://www.ncbi.nlm.nih.gov/pubmed/35402739
http://dx.doi.org/10.1016/j.ctro.2022.04.001

Ejemplares similares